Hemospry用于治疗上消化道肿瘤引起的急性出血。 （注：原文中Hemospry有误，推测正确的是Hemospray，已按正确的词翻译）
Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours.
作者信息
Arena Monica, Masci Enzo, Eusebi Leonardo Henry, Iabichino Giuseppe, Mangiavillano Benedetto, Viaggi Paolo, Morandi Elisabetta, Fanti Lorella, Granata Antonino, Traina Mario, Testoni Pier Alberto, Opocher Enrico, Luigiano Carmelo
机构信息
Digestive Endoscopy Unit, San Paolo Hospital, 20142 Milano, Italy.
Diagnostic and Therapeutic Endoscopy Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
出版信息
Dig Liver Dis. 2017 May;49(5):514-517. doi: 10.1016/j.dld.2016.12.012. Epub 2016 Dec 21.
BACKGROUND
Hemospray is a new endoscopic haemostatic powder that can be used in the management of upper gastrointestinal bleedings.
AIMS
To assess the efficacy and safety of Hemospray as monotherapy for the treatment of acute upper gastrointestinal bleeding due to cancer.
METHODS
The endoscopy databases of 3 Italian Endoscopic Units were reviewed retrospectively and 15 patients (8 males; mean age 74 years) were included in this study.
RESULTS
Immediate haemostasis was achieved in 93% of cases. Among the successful cases, 3 re-bled, one case treated with Hemospray and injection had a good outcome, while 2 cases died both re-treated with Hemospray, injection and thermal therapy. No complications related to Hemospray occurred. Finally, 80% of patients had a good clinical outcome at 30days and 50% at six months.
CONCLUSION
Hemospray may be considered an effective and safe method for the endoscopic management of acute neoplastic upper gastrointestinal bleedings.
背景
血喷粉是一种新型内镜止血粉，可用于治疗上消化道出血。
目的
评估血喷粉作为单一疗法治疗因癌症引起的急性上消化道出血的疗效和安全性。
方法
回顾性分析3个意大利内镜科室的内镜数据库，本研究纳入了15例患者（8例男性；平均年龄74岁）。
结果
93%的病例实现了即时止血。在成功的病例中，3例再次出血，1例接受血喷粉和注射治疗的患者预后良好，而2例再次接受血喷粉、注射和热疗的患者均死亡。未发生与血喷粉相关的并发症。最后，80%的患者在30天时临床预后良好，6个月时为50%。
结论
血喷粉可被认为是内镜治疗急性肿瘤性上消化道出血的一种有效且安全的方法。
Zotero 插件